Spanish Researchers Announce Pancreatic Cancer Cure With Triple Therapy

In late January 2026, scientists at Spain’s National Cancer Research Centre (CNIO) shared a major preclinical result in pancreatic cancer research. Why Pancreatic Ductal Adenocarcinoma Is So Hard to TreatMost pancreatic cancer cases are pancreatic ductal adenocarcinoma (PDAC). How This Fits Into Recent Pancreatic Cancer ProgressThis CNIO result comes during a busy stretch for pancreatic cancer research. Groups such as the Pancreatic Cancer Action Network (PanCAN) have pointed to 2026 as a major year for pancreatic cancer research, with more phase 3 trials starting or reporting results. Continued research, trial participation, and sustained funding will decide how fast this moves from mouse models to real changes in pancreatic cancer care.